PROPANC BIOPHARMA, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.9M | $-9.4M | $-3.4M | $-829.6K | $-1.4M | $-11.4M | $-2.2M | $-842.5K |
| Depreciation & Amortization | — | — | — | — | $4.1K | $1.8K | $1.9K | — |
| Depreciation | $2.2K | $877 | $81 | $538 | $4.1K | $1.8K | $1.9K | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.7M | $1.7M | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.1M | $-4.5M | $-1.4M | $226.4K | $-128.6K | $-170.3K | $-1.4M | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | $9.9K | $3.9K | $0 | — | — | $3.5K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-5.6K | $0 | — | — | $-29.2K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.1M | — | — | — | $128.5K | $170.3K | $1.4M | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | $-4.5M | $-1.4M | $226.4K | — | — | $-1.4M | — |